Genetic Analysis of 5 Alpha Reductase Type 2 Enzyme in Relation to Oxidative Stress in Cases of Androgenetic Alopecia in a Sample of Egyptian Population

October 2013 in “ Our Dermatology Online ”

Ossama Hussein Roshdy, Nagat Sobhy Mohammad, Eman Soliman Kamha, Marwa Omar

5α reductase type 2 androgenetic alopecia V89L genetic polymorphism 5-alpha reductase type II enzyme oxidative stress superoxide dismutase catalase 5-alpha reductase AGA SOD

TLDR 5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

This study analyzed the genetic polymorphism of the 5α reductase type 2 enzyme in relation to oxidative stress in cases of androgenetic alopecia (AGA) in a sample of the Egyptian population. The study found a possible association between AGA and the V89L genetic polymorphism of 5-alpha reductase type II enzyme, with patients carrying the mutant leucine (L) allele having a higher risk for developing AGA. Additionally, there was a possible association between AGA and oxidative stress, with a significant increase in the level of superoxide dismutase and catalase in patients compared to the control group. The study provides insight into the genetic factors and oxidative stress involved in AGA in the Egyptian population.

View this study on odermatol.com →

Discuss this study in the Community →

Research cited in this study

13 / 13 results

research Prevalence of Androgenic Alopecia in Women Aged 20-70 in Isfahan During 2008-2009

2 citations, December 2016 in “Journal of Pakistan Association of Dermatology”

Almost 40% of women aged 20-70 in Isfahan had hair loss, with it being more severe in those with low ferritin levels.

research Genome-Wide Scan and Fine-Mapping Linkage Study of Androgenetic Alopecia Reveals a Locus on Chromosome 3q26

62 citations, March 2008 in “American Journal of Human Genetics”

Hair loss gene found on chromosome 3q26.

research Genetic Variation in the Human Androgen Receptor Gene Is the Major Determinant of Common Early-Onset Androgenetic Alopecia

195 citations, July 2005 in “American Journal of Human Genetics”

Genetic variation in the androgen receptor gene mainly causes early-onset hair loss, with maternal inheritance playing a key role.

research Pathogenesis of Androgenetic Alopecia

52 citations, April 2004 in “Journal of The American Academy of Dermatology”

Male pattern baldness involves three mechanisms and finasteride can help reverse it.

research Family History and Risk of Hair Loss

49 citations, January 2004 in “Dermatology”

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

research Androgenetic Alopecia in Men Aged 40-69 Years: Prevalence and Risk Factors

155 citations, December 2003 in “British Journal of Dermatology”

Hair loss increases with age; alcohol raises risk, more female partners lowers it.

research Androgenetic Alopecia in Women

139 citations, June 2003 in “Journal of Investigative Dermatology Symposium Proceedings”

Androgenetic alopecia in women needs more research and better management strategies.

research Analysis of Genetic Polymorphisms of Steroid 5α-Reductase Type 1 and 2 Genes in Korean Men with Androgenetic Alopecia

15 citations, April 2003 in “Journal of Dermatological Science”

Gene differences may affect baldness treatment response in Korean men.

research Molecular Mechanisms of Androgenetic Alopecia

229 citations, August 2002 in “Experimental Gerontology”

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

research Androgenetic Alopecia and Microinflammation

131 citations, August 2000 in “International Journal of Dermatology”

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

research Antioxidants and Lipid Peroxidation Status in the Blood of Patients with Alopecia

55 citations, January 2000 in “Cell biochemistry and function”

Alopecia patients have lower antioxidants and higher lipid damage in their blood.

research Fortnightly Review: Male Pattern Androgenetic Alopecia

179 citations, September 1998 in “BMJ”

Hair loss in men is common, treatable, but not curable.

Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia

research Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia

416 citations, September 1997 in “Journal of Investigative Dermatology”

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Related Community Posts Join

6 / 92 results

community Dutasteride SAVES your hair follicles: MAJOR BS on people who say it destroyed their hair permanently.

in Finasteride/Dutasteride 160 upvotes 1 year ago

The conversation discusses the effectiveness of hair loss treatments, specifically finasteride and dutasteride. The conclusion is that dutasteride significantly reduces DHT levels and may be more effective than finasteride for long-term hair retention, with some users reporting personal experiences and side effects.

community Pirfenidone - The answer to fibrosis and baldness

in Treatment 19 upvotes 3 years ago

Pirfenidone is suggested to treat fibrosis and baldness by blocking inflammation markers and reducing collagen. It is also available as a gel for scar removal.

community Topical Finasteride Doesn't Directly Reduce 5ar Enzyme on Scalp

in Finasteride/Dutasteride 72 upvotes 1 year ago

Topical Finasteride doesn't directly reduce 5ar enzyme on scalp and has the same mechanism as oral, needing to go through the liver. Users debate the accuracy of this information and discuss various studies and experiences.

community FCE 28260: A Forgotten 5α-Reductase Inhibitor

in Research 330 upvotes 3 months ago

FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

community New and Interesting HairLoss Studies/Papers/Reviews

in Treatment 42 upvotes 4 years ago

Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

community What About Phytosterol Alternatives - Rice Bran Oil - Natural DHT Blockers

in Research/Science 4 upvotes 7 months ago

The conversation discusses natural DHT blockers like rice bran oil, which may reduce 5α-reductase activity similarly to Minoxidil and Dutasteride. One user argues that finasteride is more reliable and effective than natural alternatives.

Similar Research

5 / 1000+ results

research 5α-Reductase Type 2 Gene Variant Associations with Prostate Cancer Risk, Circulating Hormone Levels, and Androgenetic Alopecia

57 citations, February 2007 in “International Journal of Cancer”

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

research 5α-Reductase Type 2 Gene Variant Associations with Prostate Cancer Risk, Circulating Hormone Levels, and Androgenetic Alopecia

January 2008 in “The Year book of endocrinology”

Gene variant linked to prostate cancer, hormone levels, and hair loss.

5α-Reductases in Human Physiology: An Unfolding Story

Genetic Analysis of 5 Alpha Reductase Type 2 Enzyme in Relation to Oxidative Stress in Cases of Androgenetic Alopecia in a Sample of Egyptian Population

Research cited in this study

research Prevalence of Androgenic Alopecia in Women Aged 20-70 in Isfahan During 2008-2009

research Genome-Wide Scan and Fine-Mapping Linkage Study of Androgenetic Alopecia Reveals a Locus on Chromosome 3q26

research Genetic Variation in the Human Androgen Receptor Gene Is the Major Determinant of Common Early-Onset Androgenetic Alopecia

research Pathogenesis of Androgenetic Alopecia

research Family History and Risk of Hair Loss

research Androgenetic Alopecia in Men Aged 40-69 Years: Prevalence and Risk Factors

research Androgenetic Alopecia in Women

research Analysis of Genetic Polymorphisms of Steroid 5α-Reductase Type 1 and 2 Genes in Korean Men with Androgenetic Alopecia

research Molecular Mechanisms of Androgenetic Alopecia

research Androgenetic Alopecia and Microinflammation

research Antioxidants and Lipid Peroxidation Status in the Blood of Patients with Alopecia

research Fortnightly Review: Male Pattern Androgenetic Alopecia

research Different Levels of 5α-Reductase Type I and II, Aromatase, and Androgen Receptor in Hair Follicles of Women and Men with Androgenetic Alopecia

Related Community Posts Join

community Dutasteride SAVES your hair follicles: MAJOR BS on people who say it destroyed their hair permanently.

community Pirfenidone - The answer to fibrosis and baldness

community Topical Finasteride Doesn't Directly Reduce 5ar Enzyme on Scalp

community FCE 28260: A Forgotten 5α-Reductase Inhibitor

community New and Interesting HairLoss Studies/Papers/Reviews

community What About Phytosterol Alternatives - Rice Bran Oil - Natural DHT Blockers

Similar Research

research 5α-Reductase Type 2 Gene Variant Associations with Prostate Cancer Risk, Circulating Hormone Levels, and Androgenetic Alopecia

research 5α-Reductase Type 2 Gene Variant Associations with Prostate Cancer Risk, Circulating Hormone Levels, and Androgenetic Alopecia

research 5α-Reductases in Human Physiology: An Unfolding Story

research Steroid 5α-Reductase as a Novel Therapeutic Target for Schizophrenia and Other Neuropsychiatric Disorders

research 5α-Reductases in Human Physiology: An Unfolding Story